Utah Medical Products, Inc. (UTMD)
NASDAQ
74.23
-0.83 (-1.11%)
Closed
Oct 23, 2026
Day's Range
74.0475.13
52 wk Range
53.6676.89
Financial Statements - UTMD - Utah Medical Products, Inc.
Revenue
38.52M▼ 5.8%
Net Income
11.28M▼ 18.7%Net Margin 29.3%
EBITDA
11.60M▼ 11.3%
Free Cash Flow
14.32M▼ 1.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 38.52M | 40.90M | 50.22M | 52.28M | 49.05M | 42.17M |
| Cost of Goods | 16.51M | 16.76M | 20.18M | 20.08M | 18.13M | 16.63M |
| Gross Profit | 22M | 24.14M | 30.03M | 32.19M | 30.91M | 25.54M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 11.40M | 13.59M | 16.77M | 19.79M | 18.88M | 13.70M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 2.70M | 3.20M | 3.31M | 869K | 181K | 132K |
| Pre Tax Income | 14.11M | 16.80M | 20.08M | 20.65M | 19.06M | 13.84M |
| Income Tax | 2.82M | 2.92M | 3.45M | 4.18M | 4.27M | 3.04M |
| Net Income | 11.28M | 13.87M | 16.63M | 16.47M | 14.78M | 10.79M |
| EPS Basic | 3.542127 | 4.159925 | 4.582645 | 5.694322 | 4.152668 | 2.964041 |
| EPS Diluted | 3.483 | 3.961 | 4.574 | 4.522 | 4.041 | 2.941 |
| Basic Shares Outstanding | 3.18M | 3.33M | 3.63M | 3.62M | 3.65M | 3.64M |
| Diluted Shares Outstanding | 3.18M | 3.33M | 3.63M | 3.62M | 3.65M | 3.64M |
| Ebit | 11.40M | 13.59M | 16.77M | 19.79M | 18.88M | 13.70M |
| Ebitda | 11.60M | 13.07M | 20.10M | 26.21M | 25.99M | 20.80M |
| Net Income Continuous Operations | 11.28M | 13.87M | 16.63M | 16.47M | 14.78M | 10.79M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
